Company / Gross Profit per Share
NovoCure Ltd Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$4.50
FY2025
5-year range
$3.63 / $4.50
FY2021-FY2025
Trend
+3.0%
vs FY2024
Sector context
#70 of 94
Health Care
What the data says
At $4.50, NovoCure Ltd's gross profit per share ranks #70 of 94 in the Health Care sector. Improved from $3.63 to $4.50 over the past 2 years.
Based on SEC 10-K filings.
4.50 in FY2025 with a 5-year CAGR of +2.9%.
Improved from $3.63 to $4.50 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- +2.9%
- 10-Year CAGR
- -
Sector benchmark
#70 of 94 in Health CareTop 74% of 94This company $4.50 Sector average $14.63
▼
-69.2% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 3.0% year-over-year.
- Ranks #70 out of 94 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.50 | +3.0% |
| FY2024 | $4.37 | +20.5% |
| FY2023 | $3.63 | -10.8% |
| FY2022 | $4.07 | -0.9% |
| FY2021 | $4.11 | +5.4% |
| FY2020 | $3.90 | +38.3% |
| FY2019 | $2.82 | +50.0% |
| FY2018 | $1.88 | +34.7% |
| FY2017 | $1.39 | +219.2% |
| FY2016 | $0.44 | -53.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026